Ioana C. Hone
Contatto Relazioni con gli Investitori presso LINEAGE CELL THERAPEUTICS, INC.
Posizioni attive di Ioana C. Hone
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | - | - |
Storia della carriera di Ioana C. Hone
Precedenti posizioni note di Ioana C. Hone
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| LIFEVANTAGE CORPORATION | Public Communications Contact | 21/09/2010 | - |
| SAVARA INC. | Contatto Relazioni con gli Investitori | - | - |
| Public Communications Contact | - | - | |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Contatto Relazioni con gli Investitori | 12/04/2011 | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Investor Relations Contact | 3 |
| Public Communications Contact | 2 |
Settori
| Health Technology | 5 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| LIFEVANTAGE CORPORATION | Health Technology |
| SAVARA INC. | Health Technology |
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Ioana C. Hone
- Esperienza
